Results 251 to 260 of about 11,748,393 (397)

Development of gastroretentive dosage form

open access: yesEuropean Journal of Pharmaceutical Sciences, 1996
Whitehead, L, Fell, JT, Collett, JH.
openaire   +3 more sources

Interaction between Polyethylene Films and Brombexine HCl in Solid Dosage Form. II. Effects of Moisture Property on the Sorption of the Drug

open access: bronze, 1990
Takuya Kukita   +6 more
openalex   +2 more sources

The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Sphingosine‐1‐phosphate receptor modulators (S1PRM) are used to treat relapsing multiple sclerosis (MS). Each drug has a different S1PR‐subtype selectivity. They target the G‐protein coupled S1P receptors and exert significant immunomodulatory effects, such as preventing the formation of new CNS lesions and the reactivation of pre ...
Faizan Shahzad   +8 more
wiley   +1 more source

Characterization of 2-((4-(chloromethyl)benzoyl)oxy)benzoate acid for analgesic tablet dosage form formulation. [PDF]

open access: yesCurr Res Pharmacol Drug Discov
Hadinugroho W   +6 more
europepmc   +1 more source

Release of Sodium Guaiazurene-3-sulfonate from Polymer Film Dosage Forms.

open access: bronze, 1992
Kazumi Danjo   +3 more
openalex   +2 more sources

A Novel C19orf47‐AKT2 Chimeric RNA Generated by Cis‐Splicing of Adjacent Genes Is Associated With Glioblastoma Prognosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Malignant gliomas pose significant therapeutic challenges. This study aimed to identify and characterize a novel chimeric RNA in glioma and assess its clinical and functional significance for precision treatment. Methods The C19orf47‐AKT2 chimeric RNAs were identified through RNA sequencing and validated by polymerase chain reaction.
Zihan Wang   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy